CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns ...

Health insurance company Oscar Health (NYSE:OSCR) in Q4 CY2025, but sales rose 17.3% year on year to $2.81 billion. On the other hand, the company’s full-year revenue guidance of $18.85 billion at the ...

Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Small-Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.03% in ...

Oscar's total revenue for its fourth quarter of 2025 was $2.8 billion, up a robust 17% from the same period the previous year. On the other hand, the company's net loss in accordance with generally ...

Why Oscar Health has drawn fresh attention Oscar Health (OSCR) has been drawing fresh attention after a stretch of weaker ...

Oscar Health faces ACA subsidy expiration, but aggressive repricing and ICHRA expansion support a contrarian investment thesis. Analysts project FY26 revenue of $12.6bn despite anticipated 10–20% ACA ...

Oscar Health (OSCR) stock has declined by 21.7% in under a month, from $15.70 on January 26, 2026, to $12.30 currently. Should you consider purchasing this dip?

While medical costs rose, Oscar achieved notable operational efficiencies, improving its SG&A expense ratio by 160 basis ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Health insurer Oscar Health Tuesday reported a $307 million fourth quarter loss as the ...